-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
CNS Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
- CNS Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $818.000, a 36% decline year-over-year.
- CNS Pharmaceuticals, Inc. annual Depreciation for 2023 was $4.13K, a 64.8% decline from 2022.
- CNS Pharmaceuticals, Inc. annual Depreciation for 2022 was $11.8K, a 10.1% decline from 2021.
- CNS Pharmaceuticals, Inc. annual Depreciation for 2021 was $13.1K, a 17.8% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)